Vascular Access and Complications

Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

Volumn , Issue , 2009, Pages 1244-1256

  Paz, I Benjamin ^a,b  

^a Division of Oncologic Surgery   (United States)

^b NONE   (United States)

Author keywords

Algorithm for catheter related infection; Algorithm for venous thrombosis; Cardiac tamponade; Catheter related venous thrombosis; Complications related to catheter insertion; Externally tunneled catheter; Implantable subcutaneous ports; Vascular access and complications

Indexed keywords

EID: 84890758167     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303537.ch83     Document Type: Chapter

References (68)

1. Cosnett JE. The origins of intravenous fl uid therapy. Lancet 1989; 333: 768-71.
2. Roy R, Wilkinson R, Bayliss C. The utilization of long nylon catheters for prolonged intravenous infusions. Can Med Assoc J 1967; 96: 94-7.
3. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973; 136: 602-6.
4. Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-5.
5. Wenzel RP, Edmond MB. The evolving technology of venous access. N Engl J Med 1999; 340: 48-50.
6. Kumagai T, Sakamaki H, Tanikawa S et al. Utility and safety of Hickman catheters for venous access after bone marrow transplantation. Intern Med 1998; 37: 286-91.
7. Biffi R, Pozzi S, Agazzi A et al. Use of totally implantable central venous access ports for highdose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol 2004; 15: 296-300.
8. Lazarus HM, Trehan S, Miller R, Fox RM, Creger RJ, Raaf JH. Multi-purpose silastic dual-lumen central venous catheters for both collection and transplantation of hematopoietic progenitor cells. Bone Marrow Transplant 2000; 25: 779-85.
9. Harter C, Ostendorf T, Bach A, Egerer G, Goldschmidt H, Ho AD. Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies. Support Care Cancer 2003; 11: 790-4.
10. Cheong K, Perry D, Karapetis C, Koczwara B. High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours. Intern Med J 2004; 34: 234-8.
11. Beebe DS, Beck D, Belani KG. Comparison of the fl ow rates of central venous catheters designed for rapid transfusion in infants and small children. Paediatr Anaesthes 1995; 5: 35-9.
12. Horattas MC, Trupiano J, Hopkins S, Pasini D, Martino C, Murty A. Changing concepts in longterm central venous access: catheter selection and cost savings. Am J Infect Control 2001; 29: 32-40.
13. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005; 128: 489-95.
14. Restrepo A, Devore P, Encarnacion CE et al. Performance of a hybrid central venous catheter utilized for both peripheral blood stem cell harvest and transplant support of patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2002; 30: 389-95.
15. Muralidhar K. Left internal versus right internal jugular vein access to central venous circulation using the Seldinger technique. J Cardiothorac Vasc Anesth 1995; 9: 115-16.
16. Unal AE, Bayar S, Arat M, Ilhan O. Malpositioning of Hickman catheters, left versus right sided attempts. Transfus Apher Sci 2003; 28: 9-12.
17. Petersen J, Delaney JH, Brakstad MT, Rowbotham RK, Bagley CM, Jr. Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction. Am J Surg 1999; 178: 38-41.
18. Karakitsos D, Labropoulos N, De Groot E et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care 2006; 10: R162.
19. Hinke DH, Zandt-Stastny DA, Goodman LR, Quebbeman EJ, Krzywda EA, Andris DA. Pinchoff syndrome: a complication of implantable subclavian venous access devices. Radiology 1990; 177: 353-6.
20. Sadler DJ, McCarthy M, Saliken JC et al. Imageguided central venous catheter placement for apheresis in allogeneic stem cell donors. J Clin Apher 2000; 15: 173-5.
21. von Goedecke A, Keller C, Moriggl B et al. An anatomic landmark to simplify subclavian vein cannulation: the "deltoid tuberosity". Anesth Analg 2005; 100: 623-8.
22. Lorente L, Henry C, Martin MM, Jimenez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care 2005; 9: R631-5.
23. Pratila MG, Fischer ME, Alagesan R, Alagesan R, Reinsel RA, Pratilas D. Propofol versus midazolam for monitored sedation: a comparison of intraoperative and recovery parameters. J Clin Anesth 1993; 5: 268-74.
24. van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev 2007(1): CD003295.
25. Muhm M, Kalhs P, Sunder-Plassmann G, Apsner R, Brugger S, Druml W. Percutaneous nonangiographic insertion of Hickman catheters in marrow transplant recipients by anesthesiologists and intensivists. Anesth Analg 1997; 84: 80-4.
26. Andrews RT, Bova DA, Venbrux AC. How much guidewire is too much? Direct measurement of the distance from subclavian and internal jugular vein access sites to the superior vena cava-atrial junction during central venous catheter placement. Crit Care Med 2000; 28: 138-42.
27. Madden B, Paruchuru P, Kunst H. Sucking noise and collapse after central venous catheter removal. J R Soc Med 2000; 93: 592-3.
28. Muhm M. Ultrasound guided central venous access. BMJ 2002; 325: 1373-4.
29. Hind D, Calvert N, McWilliams R et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003; 327: 361.
30. Brodwater BK, Silber JS, Smith TP et al. Conversion of indwelling chest port catheters to tunneled central venous catheters. J Vasc Interv Radiol 2000; 11: 1137-42.
31. Gilon D, Schechter D, Rein AJ et al. Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation. Am Heart J 1998; 135: 457-62.
32. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a metaanalysis. Ann Intern Med 2002; 136: 792-801.
33. Gillies D, O'Riordan L, Carr D, Frost J, Gunning R, O'Brien I. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev 2003(4): CD003827.
34. Safdar N, Maki DG. Use of vancomycin-containing lock or fl ush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006; 43: 474-84.
35. Schilling S, Doellman D, Hutchinson N, Jacobs BR. The impact of needleless connector device design on central venous catheter occlusion in children: a prospective, controlled trial. JPEN J Parenter Enteral Nutr 2006; 30: 85-90.
36. Whitman ED. Complications associated with the use of central venous access devices. Curr Probl Surg 1996; 33: 309-78.
37. Ruesch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versus subclavian access - a systematic review. Crit Care Med 2002; 30: 454-60.
38. Reed MF, Lyons JM, Luchette FA, Neu JA, Howington JA. Preliminary report of a prospective, randomized trial of underwater seal for spontaneous and iatrogenic pneumothorax. J Am Coll Surg 2007; 204: 84-90.
39. Roggla M, Wagner A, Brunner C, Roggla G. The management of pneumothorax with the thoracic vent versus conventional intercostal tube drainage. Wien Klin Wochenschr 1996; 108: 330-3.
40. Meisenberg BR, Callaghan M, Sloan C, Sampson L, Miller WE, McMillan R. Complications associated with central venous catheters used for the collection of peripheral blood progenitor cells to support high-dose chemotherapy and autologous stem cell rescue. Support Care Cancer 1997; 5: 223-7.
41. Wysoki MG, Covey A, Pollak J, Rosenblatt M, Aruny J, Denbow N. Evaluation of various maneuvers for prevention of air embolism during central venous catheter placement. J Vasc Interv Radiol 2001; 12: 764-6.
42. Fletcher S, Bodenham A. Safe placement of central venous catheters: where should the tip lie? Br J Anaesth 2000; 85: 188-92.
43. Deitcher SR, Fraschini G, Himmelfarb J et al. Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patients. J Vasc Interv Radiol 2004; 15: 575-80.
44. Gorski LA. Central venous access device occlusions. Part 1. Thrombotic causes and treatment. Home Healthc Nurse 2003; 21: 115-23.
45. Deitcher SR, Fesen MR, Kiproff PM et al. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial. J Clin Oncol 2002; 20: 317-24.
46. Solomon B, Moore J, Arthur C, Prince HM. Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin. Eur J Cancer 2001; 37: 2379-84.
47. Gorski LA. Central venous access device occlusions. Part 2. Nonthrombotic causes and treatment. Home Healthc Nurse 2003; 21: 168-73.
48. Mirza B, Vanek VW, Kupensky DT. Pinch-off syndrome: case report and collective review of the literature. Am Surg 2004; 70: 635-44.
49. Dinkel HP, Muhm M, Exadaktylos AK, Hoppe H, Triller J. Emergency percutaneous retrieval of a silicone port catheter fragment in pinch-off syndrome by means of an Amplatz gooseneck snare. Emerg Radiol 2002; 9: 165-8.
50. van Rooden CJ, Schippers EF, Barge RM et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005; 23: 2655-60.
51. Kovacs MJ, Kahn SR, Rodger M et al. A pilot study of central venous catheter survival in cancer patients using low molecular weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (the catheter study). J Thromb Haemost 2007; 5: 1650-3.
52. Mandala M, Curigliano G, Bucciarelli P et al. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann Oncol 2004; 15: 590-3.
53. Hingorani A, Ascher E, Markevich N et al. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. J Vasc Surg 2005; 41: 476-8.
54. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110: 1605-11.
55. Lee AY, Levine MN, Baker RI et al. Lowmolecular- weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
56. Magagnoli M, Masci G, Castagna L et al. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients. Am J Hematol 2006; 81: 1-4.
57. Cunningham MS, White B, Hollywood D, O'Donnell J. Primary thromboprophylaxis for cancer patients with central venous catheters - a reappraisal of the evidence. Br J Cancer 2006; 94: 189-94.
58. Levine M, Kakkar AK. Catheter-associated thrombosis: thromboprophylaxis or not? J Clin Oncol 2005; 23: 4006-8.
59. Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular devicerelated bloodstream infection. Ann Intern Med 2005; 142: 451-66.
60. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006; 81: 1159-71.
61. Oppenheim BA. Optimal management of central venous catheter-related infections - what is the evidence? J Infect 2000; 40: 26-30.
62. Coyle VM, McMullan R, Morris TC, Rooney PJ, Hedderwick S. Catheter-related bloodstream infection in adult haematology patients: catheter removal practice and outcome. J Hosp Infect 2004; 57: 325-31.
63. Darouiche RO, Berger DH, Khardori N et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 2005; 242: 193-200.
64. Galloway S, Bodenham A. Safe removal of longterm cuffed Hickman-type catheters. Hosp Med 2003; 64: 20-3.
65. Reed WP, Newman KA, Tenney JH. An improved technique for the removal of long term implantable central venous lines. Surg Gynecol Obstet 1985; 161: 479-80.
66. Kohli MD, Trerotola SO, Namyslowski J et al. Outcome of polyester cuff retention following traction removal of tunneled central venous catheters. Radiology 2001; 219: 651-4.
67. Ruppel LJ, Brown RA, Borson RA, Whitman ED. Retained Hickman catheter cuff as an infection source following allogeneic bone marrow transplant. Bone Marrow Transplant 1994; 14: 169-71.
68. al-Wali WI, Wilcox MH, Thickett KJ, Simmons KM, Spencer RC. Retained Hickman catheter cuff as a source of infection. J Infect 1993; 26: 199-201.